Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

Wei Wen(Chengdu Tool Research Institute (China)), John H. Yim(Novo Nordisk (United States))
Molecular Cancer
April 30, 2015
Cited by 93


Related Papers